Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.8B | 4.9B | 5.6B | 5.7B |
Cost of revenue | 4.2B | 4.5B | 4.9B | 4.9B |
Gross profit | 564M | 368M | 758M | 795M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 129M | 125M | 50M | 45M |
Operating income | 634M | 348M | 638M | 771M |
Non operating interest income | ||||
Income | 26M | 34M | 38M | 33M |
Expense | 43M | 53M | 78M | 47M |
Other income expense | — | — | — | — |
Pretax income | 624M | 263M | 596M | 695M |
Tax provision | 222M | 182M | 276M | 295M |
Net income | 401M | 76M | 320M | 400M |
Basic EPS | 0.5 | 0.0 | 0.4 | — |
Diluted EPS | 0.5 | 0.0 | 0.4 | — |
Basic average shares | 754.2M | 753.5M | 734.0M | — |
Diluted average shares | 754.2M | 753.5M | 734.0M | — |
EBITDA | 855M | 654M | 883M | 980M |
Net income from continuing op. | 624M | 263M | 596M | 695M |
Minority interests | -39M | -42M | -51M | -38M |
Preferred stock dividends | 0 | 0 | 0 | 0 |